Evidence map›Paper›PMID 31823047›Full record

Trial reportSurgical endoscopy2020

Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial.

Chao-Hui Zheng, Yan-Chang Xu, Gang Zhao, Li-Sheng Cai, Guo-Xin Li, Ze-Kuan Xu, Su Yan, Zu-Guang Wu, Fang-Qin Xue, Yi-Hong Sun and 15 more

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Surgical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Current clinical trials on gastric cancer surgery in China.World journal of gastrointestinal oncology · 2024
    Review
  9. Article
  10. Research progress of minimally invasive surgery for gastric cancer.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Reappraise role of No. 10 lymphadenectomy for proximal gastric cancer in the era of minimal invasive surgery during total gastrectomy: a pooled analysis of 4 prospective trial.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 1 country.

Chao-Hui ZhengDepartment of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
Yan-Chang XuFujian Medicine University, Teaching Hospital, The First Hospital of PuTian City, Putian, 351100, China.
Gang ZhaoDepartment of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Li-Sheng CaiDepartment of General Surgery Unit 4, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, Fujian, China.
Guo-Xin LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Ze-Kuan XuDepartment of General Surgery, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, 210000, China.
Su YanDepartment of Gastrointestinal Surgery, Affiliated Hospital of Qinghai University, Qinghai Medical University, Xining, 810000, China.
Zu-Guang WuDepartment of General Surgery Unit 2, Meizhou People's Hospital of Guangdong, Meizhou, 514021, China.
Fang-Qin XueDepartment of Gastrointestinal Surgery, Fujian Provincial Hospital, Fuzhou, 350001, China.
Yi-Hong SunDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Dong-Bo XuDepartment of General Surgery, Longyan First Hospital, Longyan, 364000, China.
Wen-Bin ZhangDepartment of General Surgery, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Medical University, Wulumuqi, 830001, China.
Jin-WanDepartment of General Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou, 510515, China.
Pei-Wu YuDepartment of General Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Jian-Kun HuDepartment of Gastrointestinal Surgery, West China Hospital of Sichuan University, Sichuan University, Chengdu, 610000, China.
Xiang-Qian SuGastrointestinal Cancer Center, Beijing University Cancer Hospital, Beijing, 100142, China.
Jia-Fu JiGastrointestinal Cancer Center, Beijing University Cancer Hospital, Beijing, 100142, China.
Zi-Yu LiGastrointestinal Cancer Center, Beijing University Cancer Hospital, Beijing, 100142, China.
Jun YouDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361000, China.
Yong LiDepartment of Gastrointestinal Surgery, Guangdong General Hospital, Guangzhou, 510515, China.
Lin-FanDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Jun-LuDepartment of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
Ping-LiDepartment of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
Chang-Ming HuangDepartment of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, Fujian, China. hcmlr2002@163.com.ORCID 0000-0003-3370-0612
Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group
Fujian Medical University · CNPeking University · CNGuangzhou University of Chinese Medicine · CNGuangdong General Hospital · CNQinghai University · CNSun Yat-sen University · CNArmy Medical University · CNMeizhou City People's Hospital · CNNanfang Hospital · CNShanghai Jiao Tong University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious retrospective studies have shown that laparoscopic spleen-preserving D2 total gastrectomy (LSTG) for advanced upper third gastric cancer (AUTGC) is safe. However, all previous studies were underpowered. We therefore conducted a prospective, multicenter study to evaluate the technical safety and feasibility of LSTG for patients with AUTGC.

methodsPatients diagnosed with AUTGC (cT2-4a, N-/+, M0) underwent LSTG at 19 institutions between September 2016 and October 2017 were included. The number of No. 10 lymph node (LN) dissections, metastasis rates, intraoperative and postoperative complications were investigated.

resultsA total of 251 patients were enrolled in the study, and 242 patients were eligible for the per protocol analysis. The average numbers of No. 10 LN dissections and metastases were 2.4 and 0.1, respectively. Eighteen patients (7.4%) had No. 10 LN metastases, and among patients with advanced gastric cancer, the rate of No. 10 LN metastasis was 8.1% (18/223). pN3 status was an independent risk factor for No. 10 LN metastasis. Intraoperative complications occurred in 7 patients, but no patients required conversion to open surgery or splenectomy. The overall postoperative complication rate was 13.6% (33/242). The major complication and mortality rates were 3.3% (8/242) and 0.4% (1/242), respectively. The number of retrieved No. 10 LNs, No. 10 LN metastasis and TNM stage had no significant influence on postoperative complication rates.

conclusionLSTG for AUTGC was safe and effective when performed by very experienced surgeons, this technique could be used in patients who needed splenic hilar lymph node dissection.

Indexed as

Neoplasm StagingAdultAgedConversion to Open SurgeryFeasibility StudiesFemaleGastrectomyHumansLaparoscopyLymphatic MetastasisLymph Node ExcisionLymph NodesMaleMiddle AgedProspective StudiesRisk FactorsGastric cancerLaparoscopyProspective multicenter feasibility studySpleen-preserving total gastrectomy

Identifiers

PMID31823047
OpenAlexW2995719548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.